All Stories

  1. Appropriate Assessment of the Functional Consequences of Platelet Cyclooxygenase-1 Inhibition by Aspirin in vivo

    Article • Thrombosis Research, May 2014, Elsevier

    Professor Frederick A Ofosu

  2. Effective, selective and specific inhibition of COX-1 may overcome the “aspirin paradox”

    Article • Thrombosis Research, July 2013, Elsevier

    Professor Frederick A Ofosu

  3. Plasma-derived biological medicines used to promote haemostasis

    Article • Thrombosis and Haemostasis, April 2008, Schattauer GmbH

    Professor Frederick A Ofosu

  4. Propagating factor IX-producing hepatocytes for haemophilia B therapy

    Article • Thrombosis and Haemostasis, April 2008, Schattauer GmbH

    Professor Frederick A Ofosu

  5. Current use of biologicals in thrombosis and haemostasis

    Article • Thrombosis and Haemostasis, April 2008, Schattauer GmbH

    Professor Frederick A Ofosu

  6. Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases

    Article • Thrombosis Research, January 2008, Elsevier

    Professor Frederick A Ofosu

  7. HUMAN PLATELET THROMBIN RECEPTORS

    Article • Hematology/Oncology Clinics of North America, October 2000, Elsevier

    Professor Frederick A Ofosu

  8. Therapeutic approaches for haemophilia

    Article • Expert Opinion on Therapeutic Patents, June 2000, Informa Healthcare

    Professor Frederick A Ofosu

  9. Pharmacological Actions of Sulodexide

    Article • Seminars in Thrombosis and Hemostasis, April 1998, Thieme Publishing Group

    Professor Frederick A Ofosu

  10. Control Mechanisms in Thrombin Generation

    Article • Seminars in Thrombosis and Hemostasis, August 1996, Thieme Publishing Group

    Professor Frederick A Ofosu

  11. Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma Coagulation

    Article • Seminars in Thrombosis and Hemostasis, April 1995, Thieme Publishing Group

    Professor Frederick A Ofosu

  12. Thrombin-Mediated Events Implicated in Post-Thrombotic Recovery

    Article • January 1994, Springer Science + Business Media

    Professor Frederick A Ofosu

  13. Is heparin the ideal anticoagulant for cardiopulmonary bypass?

    Article • Thrombosis Research, January 1992, Elsevier

    Professor Frederick A Ofosu

  14. Prophylactically Effective Doses of Enoxaparin and Heparin Inhibit Prothrombin Activation

    Article • January 1992, Springer Science + Business Media

    Professor Frederick A Ofosu

  15. Thrombin after clot formation

    Article • Journal of Vascular Surgery, August 1990, Elsevier

    Professor Frederick A Ofosu

  16. Perspectives on the Role of Platelets in Hemostasis and Thrombosis

    Article • January 1984, Springer Science + Business Media

    Professor Frederick A Ofosu